期刊文献+

过表达CXCR4的骨髓间充质干细胞对共培养低氧/复氧肾小管上皮细胞的修复作用 被引量:3

Effect of CXCR4-overexpressing bone marrow-derived mesenchymal stem cells on the repair of the co- cultured hypoxia/re- oxygenation renal tubular epithelial cells and its possible mechanism
原文传递
导出
摘要 目的构建CXCR4质粒并转染小鼠骨髓间充质干细胞(BMSC),与低氧/复氧(hypoxia/re—oxygenation,HR)预处理的肾小管上皮细胞(RTEC)共培养,观察CXCR4-BMSC对HR—RTEC的修复效应并探讨其机制。方法采用基因转染技术获得CXCR4-BMSC(CXCR4-BMSC/eGFP,eGFP为示踪基因)和null—BMSC(BMSC/eGFP),检测转染细胞的CXCR4表达。RTEC于低氧/复氧环境中各培养12h获得HR.RETC,体外模拟急性肾损伤(AKI)细胞模型。BMSC与HR—RTEC共培养12h,免疫荧光法检测HR—RTEC的凋亡细胞比例,Western印迹法检测HR—RTEC内的凋亡相关蛋白cleavedCaspase-3和Bcl.2水平,结晶紫法计数迁移BMSC数量。以HR-RTEC上清液分别干预BMSC、CXCR4-BMSC和null—BMSC,免疫荧光法检测各组BMSC角蛋白18(CKl8)的表达,ELISA法检测BMSC上清中骨形态发生蛋白7(BMP-7)、肝细胞生长因子(HGF)和白细胞介素10(IL—lo)的浓度。结果成功转染的CXCR4.BMSC可高效表达CXCR4。HR—RTEC分别与BMSC、CXCR4-BMSC、null—BMSC共培养后,凋亡细胞比例均有下降,尤以与CXCR4.BMSC共培养组降低最为明显,并伴随着细胞内cleavedCaspase.3水平显著降低、Bcl-2表达升高(均P〈0.05)。结晶紫计数显示CXCR4-BMSC向HR—RTEC培养室的迁移数量最多。经HR—RTEC上清液干预后,BMSC、CXCR4-BMSC和null.BMSC均仅能微量表达CKl8,各组间差异无统计学意义。CXCR4过表达可显著增加BMSC的BMP-7、HGF和IL—10分泌。结论过表达CXCR4的BMSC对共培养HR—RTEC的修复效应增强,BMSC的定向迁移能力增加和迁移BMSC的分泌能力增强可能是CXCR4-BMSC的作用机制。 Objective CXCR4-overexpressing bone marrow-derived mesenchymal stem cells (CXCR4-BMSC) were constructed and co-Cultured with hypoxia/re-oxygenation pretreated renal tubular epithelial cells (HR-RTEC). Repair of HR-RTEC was detected and the possible mechanism was also discussed. Methods CXCR4-BMSC (CXCR4-BMSC/eGFP, eGFP as the tracer gene) and nnll-BMSC (BMSC/eGFP) were obtained by gene transfection technique, and the level of CXCR4 in the transfected cells was detected. RTEC was cultured under hypoxia/re-oxygenation condition for 12 h, respectively, to obtain HR-RTEC, which was used to simulate AKI in vitro. BMSC and HR-RTEC were co-cultured for 12 h, and the proportion of apoptotic cells among the HR- RTEC was assayed by immunofluorescence technique. Western blot was used to test the protein levels of cleaved Caspase-3 and Bcl- 2. The number of migrating BMSC was also assayed. After culturing with the HR- RTEC culture supernatant, the expression of cytokeratin 18 (CK18) in BMSC was tested by immunofluorescence staining. Cytokines including bone morphogenetic protein- 7 (BMP- 7), hepatic growth factor (HGF) and interleukin- 10 (IL-10) in the BMSC culture supernatant were detected by ELISA method. Results Expression of CXCR4 was enhanced in CXCR4-BMSC. Proportions of the apoptotic cells among HR-RTEC after being co-cultured with BMSC, CXCR4-BMSC and null-BMSC were all decreased, especially in the C/H group. The decreased cleaved Caspase-3 and enhanced Bcl-2 were also observed in HR-RTEC. The number of migrating CXCR4-BMSC was the highest. Proportions of CK18 ~ cells in BMSC, CXCR4- BMSC and null- BMSC were all low and showed no difference. However, CXCR4 overexpression in BMSC stimulated secretions of BMP- 7, HGF and IL- 10. Conclusions CXCR4-overexpressing BMSC has more repair effect on the co-cultured HR-RTEC, the enhanced migration ability and secretion ability of CXCR4-BMSC are the possible mechanisms.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第11期830-836,共7页 Chinese Journal of Nephrology
基金 国家自然科学基金青年项目(81300568) 全军医学科技青年培育基金(13QNP050) 上海市青年科技启明星计划项目(12QA1405000) 上海市自然科学基金(11ZRl449600) 上海市基础研究重大项目(12DJ1400203) 上海市卫生系统优秀青年人才培养计划(XYQ2013088)
关键词 骨髓间充质干细胞 肾小管上皮细胞 修复 低氧 复氧 CXCR4 Bone marrow- derived mesenchymal stem cells Hypoxia/re- oxygenation Renal tubular epithelial cells CXCR4 Repair
  • 相关文献

参考文献25

  • 1Li K,Han Q,Yan X. Not a process of simple vicariousness,the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing[J].{H}STEM CELLS AND DEVELOPMENT,2010.1267-1275.
  • 2Morigi M,Imberti B,Zoja C. Mesenchymal stem cells are renotropic,helping to repair the kidney and improve function in acute renal failure[J].{H}Journal of the American Society of Nephrology,2004.1794-1804.
  • 3Semedo P,Wang PM,Andreucci TH. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury[J].{H}TRANSPLANTATION PROCEEDINGS,2007.421-423.
  • 4T~gel F,Weiss K,Yang Y. Vasculotropic,paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury[J].{H}American Journal of Physiology Renal Physiology,2007.F1626-F1635.
  • 5Hoffmann J,Glassford A J,Doyle TC. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia[J].{H}Thoracic and Cardiovascular Surgeon,2010.136-142.
  • 6Stolzing A,Scutt A. Effect of reduced culture temperature on antioxidant defences of mesenchymal stem cells[J].{H}Free Radical Biology and Medicine,2006.326-338.
  • 7Cencioni C,Capogrossi MC,Napolitano M. The SDF-1/CXCR4 axis in stem cell preconditioning[J].{H}Cardiovascular Research,2012.400-407.
  • 8Wang Y,Luther K. Genetically manipulated progenitor/stem cells restore function to the infarcted heart via the SDF-lα/CXCR4 signaling pathway[J].Prog Mol Biol Transl Sci,2012.265-284.
  • 9Yamaguchi J,Kusano KF,Masuo O. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization[J].{H}CIRCULATION,2003.1322-1328.
  • 10Du Z,Wei C,Yan J. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts[J].{H}Liver Transplantation,2013.215-225.

二级参考文献22

  • 1Ponte AL, Marais E, Gallay N, et al. The in vitro migrationcapacity of human bone marrow mesenchymal stem cells:comparison of chemokine and growth factor chemotacticactivities. Stem Cells, 2007, 25: 1737-1745.
  • 2Togel F,Isaac J,Hu Z, et al. Renal SDF - 1 signalsmobilization and homing of CXCR4 - positive cells to thekidney after ischemic injury. Kidney Int, 2005,67: 1772-1784.
  • 3Semedo P, Wang PM, Andreucci TH, et al. Mesenchymal stemcells ameliorate tissue damages triggered by renal ischemiaand reperfusion injury. Transplant Proc, 2007, 39: 421-423.
  • 4Devine SM, Cobbs C, Jennings M, et al. Mesenchymal stemcels distribute to a wide range of tissues following systemicinfusion into nonhuman primates. Blood, 2003,101: 2999-3001.
  • 5Rjiba - Touati K,Boussema IA, Belarbia A,et al. Protectiveeffect of recombinant human erythropoietin against cisplatin -induced oxidative stress and nephrotoxicity in rat kidney. Int JToxicol, 2011, 30: 510-517.
  • 6Yang FL,Subeq YM, Chiu YH, et al. Recombinant humanerythropoietin reduces rhabdomyolysis - induced acute renalfailure in rats. Injury, 2012,43: 367-373.
  • 7Rathod DB, Salahudeen AK. Nonerythropoietic properties oferythropoietin: implication for tissue protection. J InvestigMed, 2011,59: 1083-1085.
  • 8Chen J,Li Y,Wang L, et al. Therapeutic benefit ofintracerebral transplantation of bone marrow stromal cells aftercerebral ischemia in rats. J Neurol Sci, 2001, 189: 49-57.
  • 9Barbash IM,Chouraqui P, Baron J,et al. Systemic delivery ofbone marrow - derived mesenchymal stem cells to the infarctedmyocardium : feasibility, cell migration,and body distribution.Circulation, 2003, 108: 863-868.
  • 10Horuk R. Chemokines beyond inflammation. Nature, 1998,393:524-525.

共引文献9

同被引文献22

  • 1Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogene-sis in transplants of bone marrow cells [ J] . J Embryol Exp Mor-phol,1966, 16(3) : 381 -390.
  • 2Mundra V,Gerling IC, Mahato HI. Mesenchymal stem cell-based therapy [J]. Mol Pharmaceut, 2013,10(1): 77 -89.
  • 3Xu S, De Becker A, Van Camp B , et al. An improved harvestand in vitro expansion protocol for murine bone marrow-derivedmesenchymal stem cells [ J ]. J Biomed Biotechnol, 2010,(2010) : 1 -10.
  • 4Dominici M, Le Blanc K, Mueller I,et al. Minimal criteria forSociety for Cellular Therapy position statement [ J]. Cytotherapy,2006,8(4) : 315 -317.
  • 5Vidal MA, Walker NJ, Napoli E, et al. Evaluation of senes-cence in mesenchymal stem cells isolated from equine bone mar-row ,adipose tissue, and umbilical cord tissue [J]. Stem CellsDev, 2012, 21(2) : 273 -283.
  • 6Watson N,Divers R, Kedar R,et al. Discarded Wharton jelly ofthe human umbilical cord : a viable source for mesenchymal stro-mal cells [ J] . Cytotherapy , 2015,17: 18 - 24.
  • 7Fong CY,Chak LL,Biswas A, et al. Human Wharton' s jellystem cells have unique transcriptome profiles compared to humanembryonic stem cells and other mesenchymal stem cells [ J ].Stem Cell Rev, 2011,7(1) ; 1-16.
  • 8Bhartiya D, Shaikh A, Nagvenkar P, et al. Very small embryon-ic-like stem cells with maximum regenerative potential get discar-ded during cord blood banking and bone marrow processing for au-tologous stem cell therapy [ J]. Stem Cells Dev, 2012 ,21(1): 1-6.
  • 9Lu A , Poddar M,Tang Y,et al. Rapid depletion of muscle pro-genitor cells in dystrophic mdx/utrophin ~7 ~ mice [ J] . Hum MolGenet,2014,23(18) : 4786 -4800.
  • 10Borhani-Haghighi M,Talaei-Khozani T,Ayatollahi M, et al.Wharton,s Jelly-derived mesenchymal stem cells can differentiateinto hepatocyte-like cells by HepG2 cell line extract [ J]. Iran JMed Sci, 2015,40(2) : 143 -151.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部